379 related articles for article (PubMed ID: 19305740)
1. Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.
Walker D; Lue LF
Curr Neuropharmacol; 2007 Dec; 5(4):232-43. PubMed ID: 19305740
[TBL] [Abstract][Full Text] [Related]
2. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
McGeer PL; Rogers J; McGeer EG
J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
[TBL] [Abstract][Full Text] [Related]
4. Microglial Activation and Priming in Alzheimer's Disease: State of the Art and Future Perspectives.
Bivona G; Iemmolo M; Agnello L; Lo Sasso B; Gambino CM; Giglio RV; Scazzone C; Ghersi G; Ciaccio M
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614325
[TBL] [Abstract][Full Text] [Related]
5. NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models.
Cole GM; Morihara T; Lim GP; Yang F; Begum A; Frautschy SA
Ann N Y Acad Sci; 2004 Dec; 1035():68-84. PubMed ID: 15681801
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory process in Alzheimer's Disease.
Meraz-Ríos MA; Toral-Rios D; Franco-Bocanegra D; Villeda-Hernández J; Campos-Peña V
Front Integr Neurosci; 2013; 7():59. PubMed ID: 23964211
[TBL] [Abstract][Full Text] [Related]
7. Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines.
Koenigsknecht-Talboo J; Landreth GE
J Neurosci; 2005 Sep; 25(36):8240-9. PubMed ID: 16148231
[TBL] [Abstract][Full Text] [Related]
8. Piper sarmentosum Roxb. Root Extracts Confer Neuroprotection by Attenuating Beta Amyloid-Induced Pro-Inflammatory Cytokines Released from Microglial Cells.
Chan EWL; Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY
Curr Alzheimer Res; 2019; 16(3):251-260. PubMed ID: 30819080
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
[TBL] [Abstract][Full Text] [Related]
10. Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism.
Medrano-Jiménez E; Jiménez-Ferrer Carrillo I; Pedraza-Escalona M; Ramírez-Serrano CE; Álvarez-Arellano L; Cortés-Mendoza J; Herrera-Ruiz M; Jiménez-Ferrer E; Zamilpa A; Tortoriello J; Pedraza-Alva G; Pérez-Martínez L
J Neuroinflammation; 2019 Jul; 16(1):143. PubMed ID: 31291963
[TBL] [Abstract][Full Text] [Related]
11. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
12. Metal and inflammatory targets for Alzheimer's disease.
Rogers JT; Lahiri DK
Curr Drug Targets; 2004 Aug; 5(6):535-51. PubMed ID: 15270200
[TBL] [Abstract][Full Text] [Related]
13. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation.
Anwar S; Rivest S
Expert Opin Ther Targets; 2020 Apr; 24(4):331-344. PubMed ID: 32129117
[No Abstract] [Full Text] [Related]
15. The role of inflammation in Alzheimer's disease.
Tuppo EE; Arias HR
Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
[TBL] [Abstract][Full Text] [Related]
16. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
17. New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer's Disease.
Li N; Deng M; Hu G; Li N; Yuan H; Zhou Y
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421736
[TBL] [Abstract][Full Text] [Related]
18. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
[TBL] [Abstract][Full Text] [Related]
19. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of microglial activity as a therapy for Alzheimer's disease.
Tan B; Choi RH; Chin TJ; Kaur C; Ling EA
Front Biosci (Schol Ed); 2012 Jun; 4(4):1402-12. PubMed ID: 22652882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]